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Resumen
Objetivo: evaluar si los adolescentes con mayor índice de masa corporal (IMC), o de masa grasa (IMG), en combinación con la resistencia a la insu-
lina (medida con el Modelo de Valoración Homeostática [índice HOMA]), ingieren y tienen valores más bajos de vitamina B
6
, folato y vitamina B
12
.
Métodos y materiales: seiscientos quince adolescentes participantes en el estudio Healthy Lifestyle in Europe by Nutrition in Adolescence 
(HELENA), con valores de ingesta y concentraciones de las vitaminas B
6
, folato y B
12
, e IMC, IMG y HOMA, fueron seleccionados. Las ingestas se 
midieron mediante dos recuerdos de 24 horas no consecutivos. Los biomarcadores de las vitaminas fueron obtenidos mediante cromatografía e 
inmunoensayo. Se aplicó el análisis de la covarianza para evaluar las diferencias entre las vitaminas (ingesta y concentraciones) entre las combina-
ciones de los grupos defi nidos según las medianas de los valores z de los marcadores de la composición corporal y de la sensibilidad a la insulina. 
Resultados: considerando la ingesta energética y la educación de la madre en el modelo en chicas, las ingestas de vitamin B
6
 fueron mayores 
en el grupo de mayor IMC/mayor HOMA que en el grupo mayor IMC/menor HOMA. Del mismo modo, el grupo constituido por mayor IMG/mayor 
HOMA presentó mayores ingestas de esta vitamina que el grupo formado por la combinación entre menor IMG/menor HOMA. La vitamina B
12 
plasmática en chicos fue signifi cativamente menor en el grupo formado por mayor IMG/mayor HOMA que en el grupo menor IMG/menor HOMA, 
manteniendo también la tendencia signifi cativa en los grupos, lo que también se puede observar en las chicas (p < 0.05).
Conclusiones: los adolescentes con mayor adiposidad en combinación con una mayor sensibilidad a la insulina mostraron menores valores de 
vitamina B
12
 plasmática. Estas diferencias no parecen estar explicadas por diferencias en la ingesta de vitamina B
12
.
Abstract
Objective: To assess whether adolescents with high body mass index (BMI), or fat mass index (FMI), in combination with insulin resistance 
(assessed with the Homeostatic Model Assessment [HOMA] index), had also lower blood vitamin B
6
, folate and vitamin B
12 
concentrations.
Methods and materials: Six hundred and fi fteen adolescents from the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study, 
with data on B-vitamins (both intakes and status), and BMI, FMI, HOMA, were selected. Intakes were assessed by two non-consecutive 24-h recalls. 
B-vitamins biomarkers were measured by chromatography and immunoassay. Analysis of covariance was applied to elucidate the differences in 
B-vitamins between combinations of groups defi ned according to the median of the z-scores of markers of body composition and insulin sensitivity. 
Results: When considering energy intakes and education of the mother in the model, in females, vitamin B
6
 intakes were higher in the high BMI/
high HOMA group than in the high BMI-low HOMA group. Similarly, vitamin B
6
 intakes were higher in the high FMI/high HOMA group than in the 
low FMI/low HOMA group. Plasma vitamin B
12
 was signifi cantly lower in males in the high FMI/high HOMA group than in the low FMI/low HOMA 
group, keeping also signifi cant their trends throughout the groups, a fact that can be observed also for females (p < 0.05).
Conclusion: Adolescents with combined higher adiposity and higher HOMA insulin sensitivity showed lower vitamin B
12
 plasma concentrations. 
These differences do not seem to be explained by dietary vitamin B
12
 intake. 
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INTRODUCTION 
Prevalence of overweight and obesity in European children 
ranges between 10 and 40 percent among European adolescents 
(1), while obesity is currently considered as the fifth leading risk 
for global deaths (2). Aside genetics, inadequate lifestyle factors 
like unhealthy dietary habits and/or insufficient physical activity 
are the main attributable causes of both overweight and obesity 
(3). Childhood obesity has been shown to be accompanied by 
low micronutrient intake and micronutrient deficiencies (4). For 
instance, obesity has been related to low iron intake in children 
and adolescents in a study developed in Israel (5), where obese 
children and adolescents showed a higher prevalence of iron defi-
ciency or even iron deficiency anemia than non-obese. 
The body mass index (BMI) is the most widely used height-nor-
malized index for the screening of excess body fat, also in ado-
lescents, but it can be criticized since it does not discriminate 
between lean- and fat-mass (6). Measurement of skinfolds thick-
ness allows an estimation of subcutaneous adipose tissue deposi-
tion and, thus, the use of the fat mass index (FMI = kg fat mass/
m2) instead of the BMI for classifying obesity status in children 
(6). Obesity is often associated with hyperinsulinism and insulin 
resistance, which over time can develop into in glucose intoler-
ance, impaired β-cell function and diabetes mellitus type 2 (7). 
Vitamin B
12
 is a crucial nutrient present in animal products (8). 
Its main roles are linked with the cognitive function, bone health, 
and deoxyribonucleic acid (DNA)-replication during periods of rap-
id growth and development like childhood and adolescence (9,10). 
An optimal vitamin B
12 
status during early life stages is essential 
in preventing future health risks like anemia (9). Besides, vitamin 
B
12 
deficiency contributes to hyperhomocysteinemia, which is an 
independent risk factor for atherosclerotic disease (11). Sub-clin-
ical deficiencies of vitamin B
12
 status are not uncommon during 
adolescence and in high risk population groups like vegans or 
vegetarians, elderly or low-resource people (12). 
Low vitamin B
12 
status can be due to gut malabsorption syn-
dromes, pernicious anemia (13), or secondary malabsorption 
produced by metformin therapy, an insulin sensitizer used for the 
treatment of type 2 diabetes and insulin resistance in adolescents 
(14,15).
A recent paper based on the HELENA study reported levels of 
B-related vitamins, such as B
6
, folate and B
12
 (16), in which 2% 
of studied adolescents had low plasma vitamin B
12
 and 5% had 
low holotranscobalamin (HoloTC) concentrations. Besides, low 
concentrations of both plasma folate (PF) and red blood cells 
(RBC-folate) were identified in 10% of the HELENA adolescents, 
and low pyridoxal-phosphate (PLP) concentrations were also iden-
tified in 5% of them. 
A recent Australian study with obese adolescents (13) called for 
investigation of the associations between vitamin B
12
 status and 
insulin sensitivity, including also dietary intakes. Consequently, this 
study aims to assess whether adolescents with higher body mass 
index (BMI) or fat mass index (FMI), in combination with higher 
insulin sensitivity (high Homeostatic Model Assessment [HOMA] 
index) had also lower B-vitamins concentrations.
To our knowledge, this is the first study in European adoles-
cents assessing the association between B-vitamins intake and 
concentrations and insulin sensitivity, considering indicators of 
body composition like BMI or FMI.
METHODS AND MATERIALS
The multicenter and cross-sectional study Healthy Lifestyle in 
Europe by Nutrition in Adolescence (HELENA-CSS) recruited ado-
lescents aged 12.5-17.5 years, from ten cities from nine Europe-
an countries: Athens and Heraklion, in Greece; Dortmund, in Ger-
many; Ghent, in Belgium; Lille, in France; Pécs, in Hungary; Rome, 
in Italy; Stockholm, in Sweden; Vienna, in Austria; and Zaragoza, 
in Spain. The purpose of the study was to provide complete and 
reliable information about the nutritional status of European ado-
lescents (17). Inclusion criteria were: not participating simultane-
ously in another clinical trial and being free of any acute infection 
occurring < one week before inclusion (18). The total number of 
participants was 3,528, with an average participation rate of 67%, 
which can be considered as acceptable for such a demanding 
epidemiological study (19). In one third of the sample in each 
study center (1,076 adolescents), blood drawing was obtained. 
Participants from Heraklion and Pécs (7% of the total sample) 
did not provide comparable dietary data. For the purposes of this 
analysis, 615 adolescents were included, having complete data on 
BMI, skinfold thickness to calculate FMI, maternal education, vita-
min B
6
, folate and vitamin B
12 
intakes and biomarkers, and having 
the HOMA index for insulin sensitivity or resistance excluding also 
outliers (for biochemical measurements, outliers were considered 
when values were ± four standard deviations from the mean). 
Further details on the HELENA sampling procedures, pilot study 
and reliability of the data have been published elsewhere (19). 
Informed consent was obtained from all participants and their 
parents, and the protocol was approved by the Human Research 
Review Committees of the corresponding centers (20).
ASSESSMENT OF VITAMIN B6, FOLATE, 
VITAMIN B12 AND ENERGY INTAKES 
Vitamin and energy intakes were assessed using the com-
puterized 24-hour recall, self-administered HELENA-Dietary 
Assessment Tool (HELENA-DIAT), adapted for European ado-
lescents from the Young Adolescents’ Nutrition Assessment on 
Computer (YANA-C) software (21). The adolescents completed 
the 24-hour recalls twice in a fortnight period. Trained staff were 
present during completion (21). Obtained data was linked to the 
German Food Code and Nutrient Data Base (BLS [Bundeslebens-
mittelschlüssel], version II.3.1, 2005), with 12,000 coded foods, 
and with up to 158 nutrient data points available for each food 
item (21). When traditional or local foods were not available in the 
BLS table, recipes were composed using foods from the BLS as 
ingredients. The Multiple Source Method (MSM) (22) was applied 
to calculate usual nutrient intakes removing the effect of day-to-
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day within-person variation and random error in the two recalls. 
B-vitamins diet densities were calculated as follows: (amount of 
B-vitamin intake per 1,000 kcal of diet/recommendation of the 
corresponding B-vitamin intake based on the Institute of Medi-
cine recommendations) *100. Recommendations for vitamin B
6
 
intakes are 1,300 µg in males and 1,200 µg in females; for 
folate, 400 µg in males and females; and for vitamin B
12
 2.4 µg 
in both sexes (9).
ASSESSMENT OF VITAMIN B6, FOLATE AND 
VITAMIN B12 BIOMARKERS CONCENTRATIONS 
In schools, early in the morning, and in fasting status, 30 ml 
of blood were drawn according to a standardized blood collec-
tion protocol by a certified phlebotomist. More details on sample 
transport and quality assurance can be found elsewhere (23). 
For the measurement of pyridoxal 5’phosphate (PLP), biomark-
er of vitamin B
6
, ethylene diamine tetraacetic acid (EDTA) whole 
blood was centrifuged at 3,500 g for 15 min. The supernatants 
were stored at -80 °C until analyzed. PLP was measured by high 
performance liquid chromatography (HPLC) (Varian Deutschland 
GmbH, Darmstadt, Germany; coefficient of variation [CV] = 1%) 
with a modified method of Kimura et al. (16,24).
For the measurement of plasma folate and plasma vitamin B
12
, 
heparinized tubes were collected, placed immediately on ice, and 
centrifuged within 30 min (3,500 g for 15 min). The superna-
tant fluid was transported at a stable temperature of 4-7 °C to 
the central laboratory at the University of Bonn (IEL-Institut fuer 
Ernährungs [und Lebensmittelwissebschaften], Germany) and 
stored at 80 °C until assayed. After measuring hematocrit in situ, 
EDTA whole blood was used for the red blood cell folate (RBC-fo-
late) analysis. EDTA whole blood was diluted 1:5 with freshly pre-
pared 0.1% ascorbic acid for cell lysis and incubated for 60 min 
in the dark before storage at 80 °C. Plasma and RBC-folate and 
plasma vitamin B
12
 were measured by means of a competitive 
immunoassay using the Immunolite 2000 analyzer (DPC Biermann 
GmbH, Bad Nauheim, Germany) (CV for plasma folate = 5.4%, 
RBC folate = 10.7%, cobalamin = 5.0%) (23). Sera for measuring 
holotranscobalamin (HoloTC) were obtained by centrifuging blood 
collected in evacuated tubes without anticoagulant at 3,500 g for 
15 min within one hour. Once send to the central laboratory, sera 
were aliquoted and stored at 80 °C until transport in dry ice to 
the biochemical lab at the Universidad Politécnica de Madrid for 
analysis (laboratory number 242 of the Laboratory Network of the 
Region of Madrid). HoloTC was measured by microparticle enzyme 
immunoassay (Active B
12
 Axis-Shield Ltd., Dundee, Scotland, UK) 
with the use of AxSym (Abbot Diagnostics, Abbott Park, IL, USA) 
(CV = 5.1%) (25).
Glucose was measured using enzymatic methods (Dade Beh-
ring, Schwalbach, Germany). Insulin levels were measured using 
an Immulite 200 analyzer (DPC Bierman GmbH, Bad Nauheim, 
Germany). The homeostasis model assessment (HOMA) calcula-
tion was used as a measurement of insulin resistance (glycaemia 
X insulin/22.5) (26).
CONFOUNDERS
Maternal education was used as proxy of socioeconomic status, 
obtained via self-administered questionnaire completed by the ado-
lescents and expressed as: elementary, lower secondary, higher sec-
ondary or tertiary education. This variable was one of the most related 
socioeconomic factors associated with the studied vitamins (27). Total 
energy intake in kcal/d assessed with the 24 hours’ dietary recalls 
software HELENA-DIAT was also used as a covariate in the analyses.
ANTHROPOMETRY
Anthropometry battery measurements were assessed follow-
ing standardized and strictly controlled procedures previously 
described (28). Weight was measured in underwear and without 
shoes with an electronic scale (Type SECA 861) to the nearest 
0.05 kg, and height was measured barefoot in the Frankfort plane 
with a telescopic height measuring instrument (Type SECA 225) 
to the nearest 0.1 cm. Body weight and height, together with 
subscapular and tricipital skinfold thicknesses, were measured 
in triplicate. BMI was calculated using the Quetelet formula (kg/
m2). The body fat percentage was calculated using the Slaughter’s 
equation (29), and thereafter the fat mass index (FMI) was calcu-
lated by dividing fat mass by height squared (m2).
STATISTICAL ANALYSIS
The Statistical Package for Social Sciences version 20.0 (SPSS 
Inc., Chicago, IL, USA) was used to analyze the data. All analyses 
were sex-specific. Descriptive data are presented as means and 
standard deviations (SD). Z-scores of BMI and FMI, and HOMA con-
sidering age and sex were used in the analyses. The Mann-Whitney 
test for non-parametric variables was applied to examine differenc-
es between two predefined groups, i.e., above or under the medi-
an of the z-scores for BMI, FMI, and HOMA. Thereafter, obtained 
categories were combined to create four subsequent groups to 
analyze intakes and statuses of the vitamins: low BMI (or FMI) - low 
HOMA (the most favorable group in terms of body composition and 
insulin sensitivity); low BMI (or FMI) - high HOMA; high BMI (or FMI) 
- low HOMA; and, finally, high BMI (or FMI) - high HOMA (the less 
favorable group). The Kruskal-Wallis test was applied to look at the 
differences in B-vitamin intakes and biomarkers among groups, 
with a Mann-Whitney test approach to contrast values 2 x 2. Finally, 
maternal education and total energy intakes were included in the 
analysis of covariance (ANCOVA) as covariates. All statistical tests 
and corresponding p values were two-sided, and p < 0.05 was the 
cut-off to consider a result as statistically significant. 
RESULTS
In the whole HELENA sample males represented 45%, and this 
percentage is significantly lower than in our analysis, where males 
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represented the 47% (p = 0.004). In terms of maternal education, 
included males and females showed significantly higher maternal 
education levels than those who were excluded (data not shown) 
(p < 0.001). Males included in the dietary analysis had signifi-
cantly lower energy intake (p = 0.001) than those excluded; no 
significant differences were observed in females. There was no 
statistically significant difference in biomarkers of all three vita-
mins between the samples included and excluded (based on the 
inclusion criteria and required data availability).
Table I presents the main characteristics of the sample, by sex. FMI 
and HOMA were significantly higher in females than in males whilst 
total energy intake was lower (p < 0.05). Table II presents adolescents’ 
B-vitamins intakes and biomarkers by the corresponding groups based 
on the median z-scores of variables of interest (BMI, FMI, and HOMA). 
Adolescents with low BMI, HOMA and FMI z-scores consumed more 
B-vitamins than those with high BMI, HOMA and FMI z-scores, except 
in the case of males with low HOMA, who had lower folate intakes. 
Considering biomarkers, adolescents with lower BMI, FMI and HOMA 
showed higher B-vitamins levels, except in the case of males belonging 
to the low HOMA group, who had lower RBC-folate concentrations than 
their counterparts in the higher HOMA group (p < 0.05). 
Table III shows the differences in B-vitamins both in intakes 
and concentrations among the groups defined by the subsequent 
categories of < median and > median of BMI, FMI, and HOMA 
z-scores considered in combination, without any additional adjust-
ment. All in all, results showed that adolescents belonging to the 
less favorable groups (high BMI-or FMI-/high HOMA) had lower 
B-vitamins intake and concentrations, and also lower total energy 
intakes. However, when an analysis of the covariance was per-
formed to introduce in the model the covariates of education of the 
mother and total energy intake, most of the statistically significant 
differences among groups disappeared. 
Table IV shows similarly, the adjusted results of the table II (by 
energy intakes, and maternal education). In females, vitamin B
6
 
intakes were higher in the high BMI/high HOMA group than in the 
high BMI/low HOMA group (p < 0.05). Similarly, the high FMI/high 
HOMA group vitamin B
6
 intakes were higher than in the low FMI/
low HOMA group. Plasma vitamin B
12
 in males were significantly 
lower in the high FMI/high HOMA than in the low FMI/low HOMA 
group, keeping also significant their trends throughout the groups, 
which can be observed also for females (p < 0.05). These trends 
can be followed in figure 1.
DISCUSSION
To the authors’ knowledge, this is the first study to examine the 
association between B-vitamin intakes and the corresponding bio-
marker concentrations and insulin resistance according to markers 
of body composition such as body mass index and fat mass index in 
European adolescents. The results suggest an association between 
higher adiposity together with higher insulin sensitivity and plasma 
vitamin B
12
 concentrations, showing the lowest vitamin B
12
 plasma 
concentrations in those adolescents with higher levels of adiposity 
combined with higher HOMA insulin sensitivity. Three B-vitamins 
intake and status corresponding to vitamin B
6
, folate and vitamin 
B
12
 have been investigated in this study, and we have obtained 
several differences in them in different groups constituted by the 
combinations between BMI, FMI and HOMA categories. However, 
intake of vitamin B
6
 and plasma vitamin B
12
 was the only for which 
a difference was found for categories of the mentioned groups when 
education of the mother and energy intake was taken into account.
The prevalence of insufficient vitamin B
12
 biomarker levels in 
this sample of European adolescents is low (5% based on HoloTC 
Table I. Characteristics of the participants by sex
Characteristics Males (n = 281), mean ± SD Females (n = 334), mean ± SD p-values
Age* 14.8 ± 1.3 14.8 ±1.2 0.71
BMI (kg/m2) 20.9 ± 3.6 21.2 ± 3.3 0.12
FMI (kg fat mass/m2) 12.6 ± 9.2 15.0 ± 6.8 0.03
HOMA 2.0 ± 1.2 2.2 ± 1.2 < 0.00
Energy intake (kcal/d)* 2,523 ± 816 1,892 ± 544 < 0.00
Vitamin B
6
 diet density (%)* 57.2 ± 14.8 64.8 ± 16.3 < 0.00
Folate diet density (%)* 21.8 ± 5.8 24.4 ± 6.5 < 0.00
Vitamin B
12
 diet density (%)* 104.4 ± 33.5 104.0 ± 38.0 0.43
ME: Low education (n, %) 17 (6) 29 (9) 0.17
ME: Medium-low education (n, %) 60 (21) 83 (25)
ME: Medium-high education (n, %) 92 (33) 115 (34)
ME: High education (n, %) 112 (40) 107 (32)
BMI: Body mass index; FMI: Fat mass index; HOMA: Homeostasis Model Assessment; ME: Maternal education. B-vitamins diet densities were calculated as follows: 
(amount of B-vitamin intake per 1,000 kcal of diet/recommendation of the corresponding B-vitamin intake based on the Institute of Medicine recommendations) *100. 
Recommendations for vitamin B6 intakes are 1,300 µg for males and 1,200 µg for females; for folate, 400 µg in males and females; and for vitamin B12, 2.4 µg in both 
sexes. p-values in bold are the only significant ones, based either in Mann-Whitney test or t-test* at 0.05 level two-sided.
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Table II. B-vitamin intakes and concentrations and the groups established by  
the medians of the sex-specific z-scores of body mass index, fat mass index and 
Homeostasis Model Assessment index stratified by sex
B-vitamins Males Females
< median of BMI 
z-score^ (n = 
140)
> median of BMI 
z-score^ (n = 
141)
< median of BMI 
z-score^ (n = 
167)
> median of BMI 
z-score^ (n = 
167)
Mean ± SD Mean ± SD p-value Mean ± SD Mean ± SD p-value 
Intakes
Vitamin B
6
 (µg/d) 1,925 ± 608 1,725 ± 577 0.01 1,508 ± 511 1,385 ± 446 0.02
Vitamin B
6
 diet 
density (%)
56.0 ± 13.5 58.4 ± 16.0 0.25 61.8 ± 15.3 67.9 ± 16.8 0.00
Folate (µg/d) 222 ± 73.2 206 ± 69.5 0.11 189 ± 57.2 172 ± 56.2 0.01
Folate diet density (%) 21.0 ± 4.8 22.7 ± 6.6 0.04 23.5 ± 5.6 25.4 ± 7.2 0.01
Vitamin B
12
 (µg/d) 6.6 ± 2.4 5.8 ± 2.5 0.00 4.8 ± 1.6 4.4 ± 1.7 0.00
Vitamin B
12
 diet 
density (%)
104.5 ± 32.6 104.4 ± 34.5 0.92 99.9 ± 30.9 108.1 ± 43.7 0.13
Status
PLP (pmol/l) 67.3 ± 42.0 69.3 ± 47.4 0.75 63.7 ± 80.3 62.0 ± 44.4 0.58
PF (nmol/l) 18.6 ± 9.4 18.2 ± 11.4 0.29 18.8 ± 9.3 17.8 ± 10.1 0.09
RBC-folate (nmol/l) 818 ± 328 827 ± 433 0.47 772 ± 305 761 ± 311 0.67
Plasma B
12
 (pmol/l) 358 ± 143 318 ± 115 0.04 403 ± 154 355 ± 159 0.00
HoloTC (pmol/l) 66.1 ± 36.9 64.5 ± 27.4 0.64 64.8 ± 36.1 65.7 ± 36.6 0.82
< median of FMI 
z-score (n = 140)
> median of FMI 
z-score (n = 141)
< median of FMI 
z-score (n = 167)
> median of FMI 
z-score (n = 167)
Intakes
Vitamin B
6
 (µg/d) 1,910 ± 606 1,740 ± 585 0.01 1,466 ± 458 1,426 ± 506 0.31
Vitamin B
6
 diet 
density (%)
54.8 ± 12.9 59.6 ± 16.3 0.03 62.1 ± 15.7 67.6 ± 16.5 0.02
Folate (µg/d) 222 ± 72.8 206 ± 70.0 0.07 185 ± 56.0 176 ± 57.7 0.10
Folate diet density (%) 20.8 ± 4.9 22.9 ± 6.4 0.01 23.6 ± 4.9 25.3 ± 7.1 0.02
Vitamin B
12
 (µg/d) 6.7 ± 2.5 5.7 ± 2.4 < 0.00 4.7 ± 1.5 4.5 ± 1.8 0.15
Vitamin B
12
 diet 
density (%)
104.4 ± 33.6 104.4 ± 33.6 0.95 104.4 ± 33.6 10.4.4 ± 33.6 0.13
Status
PLP (pmol/l) 65.5 ± 41.7 71.1 ± 47.3 0.24 67.1 ± 81.4 58.4 ± 41.0 0.60
PF (nmol/l) 18.5 ± 9.5 18.3 ± 11.2 0.49 19.1 ± 10.1 17.5 ± 9.3 0.07
RBC-folate (nmol/l) 825 ± 335 820 ± 428 0.40  787 ± 311 746 ± 304 0.14
Plasma B
12
 (pmol/l) 362 ± 144 313 ± 113 0.01 403 ± 165 355 ± 147 0.01
HoloTC (pmol/l) 67.6 ± 38.4 63.0 ± 24.7 0.76 66.2 ± 38.3 64.4 ± 34.3 0.99
< median of 
HOMA z-score 
(n = 140)
> median of 
HOMA z-score 
(n = 141)
< median of 
HOMA z-score 
(n = 167)
> median of 
HOMA z-score 
(n = 167)
Intakes
Vitamin B
6
 (µg/d) 1,868 ± 620 1,781 ± 579 0.20 1,431 ± 459 1,461 ± 506 0.88
Vitamin B
6
 diet 
density (%)
56.2 ± 14.2 58.1 ± 15.4 0.29 62.5 ± 15.7 67.1 ± 16.6 0.01
Folate (µg/d) 212 ± 70.4 216 ± 73.2 0.84 184 ± 57.4 178 ± 57.0 0.41
Folate diet density (%) 20.8 ± 5.1 22.9 ± 6.3 0.00 24.2 ± 6.6 24.7 ± 6.5 0.42
(Continuation in the next page)
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Table II (Cont.). B-vitamin intakes and concentrations and the groups established by 
the medians of the sex-specific z-scores of body mass index, fat mass index and 
Homeostasis Model Assessment index stratified by sex
B-vitamins Males Females
< median of 
HOMA z-score 
(n = 140)
> median of 
HOMA z-score 
(n = 141)
< median of 
HOMA z-score 
(n = 167)
> median of 
HOMA z-score 
(n = 167)
Intakes
Vitamin B
12
 (µg/d) 6.5 ± 2.7 5.9 ± 2.2 0.04 4.6 ± 1.7 4.5 ± 1.7 0.65
Vitamin B
12
 diet 
density (%)
105.5 ± 35.0 103.3 ± 32.1 064 101.5 ± 37.4 106.4 ± 38.6 0.18
Status
PLP (pmol/l) 67.4 ± 42.0 69.1 ± 47.3 1.0 67.5 ± 79.1 58.2 ± 46.3 0.24
PF (nmol/l) 18.9 ± 10.7 17.9 ± 10.1 0.43 19.6 ± 10.4 17.0 ± 8.9 0.00
RBC-folate (nmol/l) 815 ± 395 829 ± 373 0.74 766 ± 285 766 ± 329 0.70
Plasma B
12
 (pmol/l) 354 ± 132 322 ± 129 0.03 397 ± 160 361 ± 154 0.03
HoloTC (pmol/l) 70.1 ± 40.4 60.5 ± 20.6 0.17 67.8 ± 40.1 62.8 ± 32.1 0.33
BMI: Body mass index; FMI: Fat mass index; HOMA: Homeostasis Model Assessment; PLP: Pyridoxal phosphate; PF: Plasma folate; RBC-folate: Red blood cell 
folate; HoloTC: Holotranscobalamin; SD: Standard deviation. B-vitamins diet densities were calculated as follows: (amount of B-vitamin intake per 100 kcal of diet/
recommendation of the corresponding B-vitamin intake based on the Institute of Medicine recommendations) *100. Recommendations for vitamin B6 intakes are  
1,300 µg for males and 1,200 µg for females; for folate, 400 µg in males and females; and for vitamin B12, 2.4 µg in both sexes. p-value based on Mann-Whitney 
non-parametric test. Statistical significance at 0.05 two-sided level. ^Sex-specific z-scores of BMI, FMI and HOMA were adjusted by age. 
(Continuation in the next page)
Table III. Differences of B-vitamin intakes and biomarkers concentrations by resulting 
combination groups between z-scores of body mass index and fat mass index against 
z-scores of insulin resistance (HOMA) index
Males
Energy 
intake 
(mean, SD)
Vitamin 
B6 (mean, 
SD)
Folate 
(mean, 
SD)
Vitamin 
B12 
(mean, 
SD)
PLP 
(mean, 
SD)
PF (mean, 
SD)
RBC-
folate 
(mean, 
SD)
Plasma 
B12 (mean, 
SD)
HoloTC 
(mean, 
SD)
BMI by HOMA (n)
Low BMI-low 
HOMA (91)
2,659 ± 783a 1,910 ± 618a 215 ± 71 6.7 ± 2.4ab 65.7 ± 40.8 18.3 ± 8.7 782 ± 300 366 ± 142a 70.3 ± 43.5
Low BMI- 
high HOMA 
(49)
2,763 ± 893 1,953 ± 596 236 ± 77.0 6.3 ± 2.4 70.3 ± 44.4 19.1 ± 10.5 882 ± 370 342 ± 147 58.5 ± 17.6
High BMI-low 
HOMA (49)
2,502 ± 800 1,791 ± 552 208 ± 70.4 6.1 ± 3.1a 70.8 ± 44.6 20.0 ± 13.7 877 ± 525 330 ± 111 69.7 ± 34.6
High BMI-high 
HOMA (92)
2,273 ± 757a 1,689 ± 552a 206 ± 69.5 5.6 ± 2.1b 68.5 ± 49.0 17.3 ± 9.9 801 ± 373 311 ± 117a 61.6 ± 22.1
p-value < 0.00 0.03 0.19 0.01 0.97 0.64 0.55 0.08 0.44
FMI by HOMA (n)
Low-FMI-low 
HOMA (86)
2,660 ± 770a 1,903 ± 628a 215 ± 69.1 6.8 ± 2.5ab 65.5 ± 41.1 18.5 ± 9.1 778 ± 296 366 ± 141a 71.5 ± 44.7
Low FMI-high 
HOMA (54)
2,843 ± 952 1,921 ± 569 235 ± 78.1 6.4 ± 2.4 65.6 ± 43.5 18.6 ± 10.4 908 ± 385 357 ± 149.0 60.4 ± 20.7
High FMI-low 
HOMA (54)
2,504 ± 822 1,805 ± 605 208 ± 73.1 6.0 ± 2.9a 71.1 ± 44.0 19.7 ± 13.2 882 ± 525 332 ± 113 67.5 ± 30.7
High FMI-high 
HOMA (87)
2,223 ± 677a 1,704 ± 574a 206 ± 68.6 5.6 ± 2.0b 71.0 ± 49.3 17.5 ± 9.9 785 ± 361 302 ± 112a 60.6 ± 20.7
p-value < 0.00 0.06 0.17 0.00 0.68 0.83 0.21 0.02 0.57
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Table III (Cont.). Differences of B-vitamin intakes and biomarkers concentrations by 
resulting combination groups between z-scores of body mass index and fat mass index 
against z-scores of insulin resistance (HOMA) index
Females
Energy 
intake 
(mean, SD)
Vitamin 
B6 (mean, 
SD)
Folate 
(mean, 
SD)
Vitamin 
B12 
(mean, 
SD)
PLP 
(mean, 
SD)
PF (mean, 
SD)
RBC-
folate 
(mean, 
SD)
Plasma 
B12 (mean, 
SD)
HoloTC 
(mean, 
SD)
BMI by HOMA (n)
Low BMI-low 
HOMA (100)
2,045 ± 483ab 1,511 ± 488a 194 ± 52.4ab 4.8 ± 1.6ab
64.7 ± 
94.4a
19.7 ± 9.3ab 779 ± 290 418 ± 149ab 67.2 ± 33.7
Low BMI-high 
HOMA (67)
2,043 ± 544 1,502 ± 546 181 ± 63.4 4.8 ± 1.5 62.2 ± 54.4 17.5 ± 9.2a 760 ± 329 380 ± 159 61.3 ± 39.5
High BMI-low 
HOMA (67)
1,762 ± 449a 1,312 ± 386a 168 ± 61.5a 4.3 ± 1.7a
71.6 ± 
49.1a
19.4 ± 11.9 747 ± 280 366 ± 172a 68.8 ± 48.3
High BMI-high 
HOMA (100)
1,727 ± 595b 1,433 ± 478 175 ± 52.6b 4.4 ± 1.7b 55.5 ± 39.9 16.7 ± 8.7b 770 ± 331 348 ± 151b 63.7 ± 26.6
p-value < 0.00 0.05 0.01 0.02 0.04 0.02 0.95 0.00 0.47
FMI by HOMA (n)
Low FMI-low 
HOMA (102)
1,995 ± 437ab 1,466 ± 417 189 ± 51.1 4.7 ± 1.5 70.0 ± 94.7 19.9 ± 10.4a 790.7 ± 294 421 ± 159abc 67.6 ± 35.4
Low FMI-high 
HOMA (65)
1,995 ± 554 1,467 ± 520 180 ± 64.1 4.7 ± 1.5 63.4 ± 56.1 17.8 ± 9.7 780 ± 339 374 ± 157a 63.9 ± 42.6
High FMI-low 
HOMA (65)
1,832 ± 550a 1,377 ± 517
175.4 ± 
65.7
4.5 ± 1.9 64.2 ± 44.6 19.0 ± 10.4 728 ± 268 359 ± 156b 68.1 ± 46.8
High FMI-high 
HOMA (102)
1,764 ± 604b 1,457 ± 499 176 ± 52.3 4.5 ± 1.7 54.8 ± 38.3 16.6 ± 8.4a 757 ± 324 353 ± 142c 62.0 ± 23.4
p-value < 0.00 0.64 0.24 0.54 0.35 0.02 0.51 0.01 0.57
BMI: Body mass index; HOMA: Homeostasis Model Assessment; FMI: Fat mass index; PLP: Pyridoxal phosphate; PF: Plasma folate; RBC-folate: Red blood cell folate; 
HoloTC: Holotranscobalamin; SD: Standard deviation. p-value based on Kruskal-Wallis non-parametric test. Statistical significance was established at 0.05 two-sided 
level. Superscripts letters represent those groups with statistical significant differences. Post hoc comparisons between groups have been established based on  
Mann-Whitney test. Statistical significance critical value established at 0.0167 two-sided level (resulting from dividing 0.05/3 comparisons with the reference category 
of “low BMI (or FMI)-low HOMA” which represents the more favorable option).
and 2% based on serum B
12
) (30), and corresponds approximately 
to the prevalence of inadequate vitamin B
12 
intakes reported previ-
ously (2.9% in males and 6.0% in females) (8) in a larger sample 
of the same adolescents. In other studies performed in Australia 
and Canada, the percentage of adolescents identified with low 
or borderline B
12
 status was higher than the one reported in our 
European adolescents (respectively, 32.1% in obese adolescents 
in the study from Australia (13), or 13.7% in all children and 
adolescents and 20.4% only in obese children and adolescents 
reported in the Canadian survey (31) using the same cut-points as 
in the Australian study). However, these percentages of low vitamin 
B
12 
status refer exclusively to overweight/obese adolescents, and 
this could be the cause of such big differences with ours. 
In our sample, 23.3% (32) of the adolescents were classified 
as overweight or obese. Even with these differences in rates of 
overweight/obesity and deficiency or not of vitamin B
12
 between 
our study and the Australian study (13), our results confirm the 
association between lower levels of vitamin B
12
 and higher HOMA 
and FMI. Besides, this negative association between vitamin B
12
 
plasma levels and values of insulin sensitivity and body composi-
tion markers are likely reproducible for other micronutrients (total 
carotenoids, alpha-carotene, beta-carotene, beta-cryptoxanthin, 
lutein/zeaxanthin, lycopene, vitamin E, vitamin C, selenium, vita-
min A, vitamin D, folate, vitamin B
12
, and RBC-folate), as reported 
in a study of US adults (33). 
There are no previous studies investigating the same asso-
ciations in a similar population group. Nevertheless, previous 
studies (4,13,31) focused on obese adolescents or wide general 
population groups have also found that higher BMI z-scores were 
associated with lower vitamin B
12
 concentrations, with no signif-
icant gender effect. 
There are several mechanisms which might explain this 
observation. For instance, adolescents have increased nutrient 
requirements secondary to increased growth and body size (34). 
Another reason is that adolescents with high BMI are thought to 
have diets with low micronutrient density. In our study, we found 
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lower B-vitamins intake in adolescents with higher BMI while they 
have higher B-vitamins density diets. This can be explained by 
the fact that in the HELENA study, adolescents with higher BMI 
reported lower total energy diets likely affected by underreporting 
(35). Another reason could be that obese adolescents may have 
repeated short-term restrictive diets (34); this could be the case 
in our study (35), because adolescents with high BMI and high 
FMI were those with lower total energy intakes. 
There were several differences between groups constituted by 
the combination of body composition markers and HOMA insu-
lin sensitivity in terms of B-vitamins biomarkers concentrations. 
However, only adolescents belonging to the most favorable group 
in terms of combination between FMI and HOMA (lower FMI com-
bined with lower HOMA) have higher plasma vitamin B
12
 concen-
trations, as it had been already shown by another study (13). How-
ever, the previous study did not include the analyses of B-vitamins 
dietary intake, as it has being shown in our study. This fact cannot 
be explained by higher vitamin B
12
 intakes but it might be due to 
lower vitamin B
12
 density diets in comparison to those adolescents 
belonging to the less favorable combination groups, as shown in 
table II, likely resulting from the restrictive diets or underreporting 
behaviors previously mentioned. Besides, while we have obtained 
statistically significant differences for vitamin B
6
 intake regarding 
BMI and FMI based on the median categories combined with the 
categories of HOMA, this was not the case for vitamin B
12
. This 
is of lots of interest owing to the fact that plasma vitamin B
12
 is 
supposed to reflect changes in day-to-day diet rather than HoloTC, 
which is more efficient in predicting long-term diet changes (9), for 
which no difference among categories has been found. 
Given that there seems not to be a plausible effect of adi-
posity and insulin resistance on plasma vitamin B
12
 concen-
trations, linked to vitamin B
12
 intake, we should consider the 
hypothesis that low vitamin B
12
 concentrations could influ-
ence insulin resistance. A recent genome-wide analysis (36) 
suggested that increased DNA methylation is associated with 
increased BMI in adults, and vitamin B
12
 is a determinant for 
DNA methylation. 
Also, in a recent review about the transmission of obesity-ad-
iposity and related disorders from the mother to the newborns 
(37), it is mentioned that in rural areas from India, with mothers 
consuming mainly vegetarian diets, the most insulin-resistant 
children were born to mothers who had low vitamin B
12
 but high 
folate levels, suggesting that a balance between these two vita-
mins is essential. This might be a consequence from the fact that 
folate together with vitamins B
12
 and B
6
, among others, regulate 
maternal 1-carbon metabolism, which influences cellular growth 
and differentiation by helping synthesis of nucleic acids. However, 
this explanation is not helpful to understand our results, owing to 
the differences in the characteristics of the population group and 
because our sample showed higher prevalence of folate deficiency 
than the vitamin B
12
 one (30). 
Other study (38) showed the importance of levels of homocyste-
ine in insulin resistance with an improvement of it with a lowering 
homocysteine by folate + vitamin B
12
 treatment and a correlation 
of 0.60 between homocysteine levels and insulin resistance, as 
was also shown by similar studies. 
Our findings might be of particular concern in case of adoles-
cents diagnosed as obese patients because they will be prone 
to a further decrease in vitamin B
12
 concentrations if metformin 
therapy is recommended for the treatment of type 2 diabetes (15). 
For instance, in adults, vitamin B
12
 malabsorption was observed 
in approximately 20% of patients using metformin, and this was 
associated with a 4-24% decrease of vitamin B
12 
concentrations 
(39). 
LIMITATIONS AND STRENGTHS
The cross-sectional design of the study represents a limita-
tion owing to the fact that causality cannot be established. The 
clinical interpretation of our findings is unclear because a very 
low percentage of adolescents presented inadequate intakes 
or very low serum concentrations of vitamin B
12
. However, the 
observed association between vitamin B
12
 plasma level and body 
composition and insulin resistance warns us about the impor-
tance of having a healthy nutritional status and elucidates the 
fact that overweight or obese people cannot get nutritional defi-
ciencies. The use of harmonized and standardized procedures 
in a large sample of adolescents from Europe (18) should be 
considered as the main strength of the study, as well as the use 
of previously validated questionnaires and procedures (18,19). 
Besides, the calculation of the usual intake values based on 
the MSM method to prevent limitations of the 24-h recalls (22), 
together with the use of widely accepted micronutrient biomark-
ers, strengthen the reliability of the observations with any other 
marker or symptom (40).
Figure 1. 
Plasma vitamin B
12
 concentrations (pmol/L) according to the combination between 
categories of FMI and HOMA by sex.
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CONCLUSION
Obesity is not only associated with cardiovascular conditions, 
cancer, dyslipidemias, etc., but also with micronutrient deficien-
cies which can lead to serious health problems. Among vitamins 
B
6
, folate, and B
12
, it seems that vitamin B
12
 is the one most 
consistently and negatively associated with BMI, FMI, and insulin 
sensitivity or resistance (HOMA) without discriminating between 
sexes of European adolescents. 
In male and female adolescents with combined higher adiposity 
measured with fat mass index and higher HOMA insulin sensitiv-
ity, low vitamin B
12
 plasma concentrations were observed. These 
differences do not seem explained by dietary vitamin B
12
 intake. 
Further studies are necessary to elucidate the potential role of low 
vitamin B
12
 concentrations in the development of insulin resistance 
in adolescents in order to identify a plausible biological mechanism. 
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